Showing results (31-40 of 355) with videos related to
Sort By:
Pageof 36
Kidney International|April 29, 1998
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathyP Jacobsen, K Rossing, P Rossing, et al.Diabetes Care|March 31, 1999
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up studyH H Parving, L Tarnow, F S Nielsen, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1P Hovind, L Tarnow, P Rossing, et al.Kidney International. Supplement|July 21, 1999
Progression of diabetic nephropathy in normotensive type 1 diabetic patientsP Jacobsen, K Rossing, L Tarnow, et al.Diabetologia|February 23, 1999
Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathyA Sato, L Tarnow, H H ParvingDiabetes Care|September 4, 1998
Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathyA Sato, L Tarnow, H H ParvingDiabetologia|October 6, 2009
Telomere length predicts all-cause mortality in patients with type 1 diabetesA S Astrup, L Tarnow, A Jorsal, et al.Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.Diabetes|March 1, 1996
Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathyL Tarnow, F Cambien, P Rossing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathyL Tarnow, F Cambien, P Rossing, et al.Pageof 36